Search results

Search for "rivaroxaban" in Full Text gives 2 result(s) in Beilstein Journal of Organic Chemistry.

Evaluation of the enantioselectivity of new chiral ligands based on imidazolidin-4-one derivatives

  • Jan Bartáček,
  • Karel Chlumský,
  • Jan Mrkvička,
  • Lucie Paloušová,
  • Miloš Sedlák and
  • Pavel Drabina

Beilstein J. Org. Chem. 2024, 20, 684–691, doi:10.3762/bjoc.20.62

Graphical Abstract
  • enhanced economic efficiency, eco-friendly practices, and reduced waste. Catalysts with the highest enantioselectivity have been employed in the synthesis of essential chiral intermediates for drug production, such as amprenavir [12], rivaroxaban [13][14], linezolid [13] and salmeterol [7]. Therefore
PDF
Album
Supp Info
Full Research Paper
Published 02 Apr 2024

The asymmetric Henry reaction as synthetic tool for the preparation of the drugs linezolid and rivaroxaban

  • Martin Vrbický,
  • Karel Macek,
  • Jaroslav Pochobradský,
  • Jan Svoboda,
  • Miloš Sedlák and
  • Pavel Drabina

Beilstein J. Org. Chem. 2022, 18, 438–445, doi:10.3762/bjoc.18.46

Graphical Abstract
  • antibiotic linezolid (1) and the anticoagulant rivaroxaban (2) – belong among modern pharmaceutics, which contain an oxazolidine-2-one moiety bearing a stereogenic center. The chirality of these drugs is a fundamental attribute for their biological activity. Herein, one of the efficient asymmetric syntheses
  • syntheses of these drugs were obtained in high yields and enantiomeric excesses of up to 91% ee. Keywords: asymmetric Henry reaction; enantioselective catalysis; linezolid; oxazolidine-2-one derivatives; rivaroxaban; Introduction Oxazolidine-2-one derivatives represent an important branch of
  • pharmaceutical substances [1][2][3]. This class includes for instance oxazolidine-type antibiotics [3], e.g., linezolid (1) [4] (sold under the trade name Zyvox® (Figure 1) or tedizolid [5] (sold under the trade name Sivextro®), and the anticoagulant rivaroxaban (2) [6][7] (Figure 1), a member of DOACs (direct
PDF
Album
Supp Info
Full Research Paper
Published 14 Apr 2022
Other Beilstein-Institut Open Science Activities